Larissa Korde News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p style="text-align:start">In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.&nbsp;These and other results of the analyses are presented as a proffered paper (Abstract LBA48) at the European Society of Medical Oncology (ESMO) Congress 2023 in Madrid, Spain, on Monday, October 23, by Sapna P. Patel, MD, chair of the SWOG melanoma committee and associate professor of melanoma medical oncology at the University of Texas MD Anderson Cancer Center.</p>

United statesVernonk sondakMichaelc loweAparna hegdeJohnm kirkwoodKaiser permanenteThach giao truongElizabethi buchbinderLarissa kordeG paul wrightPhyllis gyorkeyAntoni ribasVictorg prietoSapnap patelMegan othusKari kendra